• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BXN 9.09% 1.2¢

BIOXYNE LIMITED

Bioxyne Limited is an Australia-based health and wellness products company. Its activity... Bioxyne Limited is an Australia-based health and wellness products company. Its activity is the development, manufacture and distribution of nutritional health and wellness supplements through indirect wholesale and direct sales channels in the health and wellness sector. It is engaged in the consumer dietary supplements and functional foods markets through its probiotic, Lactobacillus fermentum VRI-003 (PCC). The Company has developed a range of functional food and beauty products containing ingredients sourced primarily from New Zealand, through its direct sales business trading as Bioxyne International. It has an interest in Breathe Life Sciences (BLS). It has operations across Australia, the United Kingdom, Japan, Europe and Southeast Asia with a health and wellness product portfolio, including health supplements, skincare, probiotics, cannabis-derived raw materials, starting materials, active pharmaceutical ingredients, cannabinoid-based therapies and telemedicine technology.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
BXN
DONT FALL IN THE TRAP
28/03/24 0 90
28/03/24 Last post  pakkham Comments Created with Sketch.  0  Views Created with Sketch.  90 
BXN 25/03/24 0 157
25/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  157 
BXN 25/03/24 0 146
25/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  146 
BXN 22/03/24 0 105
22/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  105 
BXN 22/03/24 0 107
22/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  107 
BXN
News: BXN Bioxyne Posts HY Loss Attributable A$12.3 Million
13:05 0 125
13:05 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  125 
BXN 12:58 0 219
12:58 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  219 
BXN
News: BXN Bioxyne Says Awarded Gmp Manufacturing License For Medical Cannabis
07/02/24 2 891
07/02/24 Last post  pakkham Comments Created with Sketch.  2  Views Created with Sketch.  891 

See All Discussions arrow Created with Sketch.

Timeline

Bioxyne to Host Webinar on 28 March 2024
25 Mar 14:23
 
Investor Presentation
25 Mar 09:57
 
Notification regarding unquoted securities - BXN
22 Mar 14:28
 
Notification of cessation of securities - BXN
22 Mar 14:22
 
Half Yearly Report and Accounts
29 Feb 12:38
 
BXN Awarded GMP Manufacturing License for Medical Cannabis
05 Feb 08:19
 
View More arrow Created with Sketch.
(20min delay)
Last
1.2¢
Change
0.001(9.09%)
Mkt cap ! $22.82M
Open High Low Value Volume
1.1¢ 1.2¢ 1.1¢ $17.55K 1.514M

Buyers (Bids)

No. Vol. Price($)
1 400000 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.2¢ 633982 2
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
1.2¢
  Change
0.001 ( 9.09 %)
Open High Low Volume
1.2¢ 1.2¢ 1.2¢ 90865
Last updated 10.39am 29/03/2024 ?
BXN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.